Musa, Jonah
Maiga, Mamoudou
Green, Stefan J.
Magaji, Francis A.
Maryam, Ali J.
Okolo, Mark
Nyam, Chuwang J.
Cosmas, Nanma T.
Silas, Olugbenga A.
Imade, Godwin E.
Zheng, Yinan
Joyce, Brian T.
Diakite, Brehima
Morhason-Bello, Imran
Achenbach, Chad J.
Sagay, Atiene S.
Ujah, Innocent A.O.
Murphy, Robert L.
Hou, Lifang
Mehta, Supriya Dinesh
Funding for this research was provided by:
Fogarty International Center (K43TW011416, K43TW011416, K43TW011416, K43TW011416, K43TW011416, K43TW011416)
National cancer institute (U54CA221205, U54CA221205, U54CA221205, U54CA221205, U54CA221205, U54CA221205, U54CA221205, U54CA221205, U54CA221205)
Article History
Received: 7 December 2022
Accepted: 17 July 2023
First Online: 20 July 2023
Declarations
:
: The authors have no competing interest to declare.
: The research protocol for this study with informed consent for the enrollment procedures were reviewed and approved by the Jos University Teaching Hospital’s Health and Research Ethics Committee. The approval reference for the research protocol is: <b><i>JUTH/DCS/ADM/127/XXIX/1546</i></b>. All participants signed an informed consent for all enrollment procedures which were conducted in accordance with the relevant regulatory guidelines as in the Helsinki’s declaration.
: All participant provided informed consent for publication of research findings as summary with no identifiable personal information.